Stacey Roberts MD in Ankeny, Iowa

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: University Of Iowa, Rj & L Carver College Of Medicine
Graduation Year: 1997
The Primary Medical Specialty for Stacey Roberts MD is listed as: Gastroenterology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 27
PAC (PECOS ID)#: 5698782183
NPI #: 1912965146
NPI Created On: 05/04/2006
NPI Last Updated Listed as: 05/06/2015
Primary Taxonomy Code: 207RG0100X
License Number:
34960
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Medica Insurance Company
• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, German.

Services and Procedures include:

1. Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope
2. Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope
3. Diagnostic examination of large bowel using an endoscope
4. Biopsy of large bowel using an endoscope
5. Removal of polyps or growths of large bowel using an endoscope
6. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
7. Infusion of chemotherapy into a vein up to 1 hour
8. Infusion of chemotherapy into a vein
9. Established patient office or other outpatient visit, typically 15 minutes
10. Initial hospital inpatient care, typically 50 minutes per day
11. Subsequent hospital inpatient care, typically 25 minutes per day
12. Physician telephone patient service, 11-20 minutes of medical discussion
13. Colorectal cancer screening; colonoscopy on individual at high risk
14. Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk
15. Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito
16. Injection, infliximab, excludes biosimilar, 10 mg
17. Injection, vedolizumab, 1 mg